Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-05-07
1992-03-17
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514402, 514826, 514851, 424 45, A61K 31415, A61L 904
Patent
active
050969161
ABSTRACT:
A method of using an imidazoline compound, which is a vasodilator and an alpha-adrenergic blocking agent, for the treatment of symptoms of chronic obstructive pulmonary diseases (COPD), including cystic fibrosis, chronic bronchitis and emphysema, or COPD where it is associated with asthma, comprises administering the imidazoline to a patient by inhalation. Preferably, the imidazoline compound employed is tolazoline. The presentation of an imidazoline compound in a device for the administration of an aerosol is disclosed.
REFERENCES:
patent: 2161938 (1939-06-01), Sonn
patent: 4255439 (1981-03-01), Cooper
Kelminson et al., Pediatrics, vol. 39(1), pp. 24-35, Jan. 1967.
Feather et al., Thorax, vol. 25(b), pp. 732-736, Nov. 1970.
Gross et al., Chest., 66, 397 (1974).
Scholz, Industrial and Engineering Chemistry, 37, 120 (1945).
Gennard, Ed., Remington's Pharmaceutical Scienses, 17th Edition, 1672-1675, 1834-1835 (1985).
Waldon et al., Am. Rev. Respir. Dis., 130, 357 (1984).
Barnes et al., J. of Allergy and Clinical Immunology, 68, 411 (1981).
Cotton, E. K., "Tolazoline in the Treatment of Cystic Fibrosis", The Society for Pediatric Research Program and Abstracts of the 36th Annual Meeting, p. 51, (1966).
Cotton, E. K., "Tolazoline in the Treatment of Cystic Fibrosis", The Society for Pediatric Research Program and Abstracts of the 36th Annual Meeting, p. 51, (1966).
Aegis Technology, Inc.
Waddell Frederick E.
Woddington Ke. F.
LandOfFree
Treatment of chronic obstructive pulmonary disease (COPD) by inh does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of chronic obstructive pulmonary disease (COPD) by inh, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of chronic obstructive pulmonary disease (COPD) by inh will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1476122